U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C13H20N2O2
Molecular Weight 236.3101
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DROPROPIZINE

SMILES

OCC(O)CN1CCN(CC1)C2=CC=CC=C2

InChI

InChIKey=PTVWPYVOOKLBCG-UHFFFAOYSA-N
InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2

HIDE SMILES / InChI

Molecular Formula C13H20N2O2
Molecular Weight 236.3101
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Dropropizine is a cough suppressant. It has peripheral action in non-productive cough. Dropropizine is commercialized in Latin American and African countries.

CNS Activity

Originator

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
TROFERIT

PubMed

Sample Use Guides

In Vivo Use Guide
30 mg 6 or 8 hourly
Route of Administration: Oral
In Vitro Use Guide
When the Chinese hamster V79 cells were treated with the highest concentration of Dropropizine (8000 ug/ml), cytostatic effects lasting 24 h were observed
Substance Class Chemical
Record UNII
U0K8WHL37U
Record Status Validated (UNII)
Record Version